Axa’s Lydall, Inc. LDL Stock Holding History

Axa’s Portfolio LDL Stock Details LDL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q1	–	Sell	-4,399	Closed	-$78K	–	1479
2013 Q4	$78K	Hold	4,399	–	–	﹤0.01%	1301
2013 Q3	$76K	Hold	4,399	–	–	﹤0.01%	1201
2013 Q2	$64K	Buy	+4,399	New	+$63.4K	﹤0.01%	1185

Other funds holding LDL

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

VDBMI

Van Den Berg Management I Austin, Texas $436M AUM 40.66% 1-Year Est. Return

Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

GWI

Grace & White Inc Ny, New York $632M AUM 34.34% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Axa's LDL Position: Q1 2014 in Review

Axa sold out of Lydall, Inc. (LDL) in Q1 2014, closing a stake of 4,399 shares — an estimated $78K sold.

Axa first reported a position in LDL in Q2 2013 and held it in 3 quarters. The position peaked at $78K in Q4 2013. 114 funds tracked by Wall St. Rank hold LDL as of Q1 2014.

Axa reported no remaining Lydall, Inc. position as of Q1 2014 after selling out during the quarter.
Axa sold 4,399 Lydall, Inc. shares in Q1 2014, an estimated $78K.
Axa first reported a position in Lydall, Inc. in Q2 2013 and held it in 3 quarters.
Axa's Lydall, Inc. position peaked at $78K in Q4 2013.
114 funds tracked by Wall St. Rank held Lydall, Inc. as of Q1 2014.

Based on Axa's 13F filing for Q1 2014, filed 13 May 2014.